4-((3-Allyl-2-hydroxybenzylidene)amino)-3-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione

Catalog No. :
ACQSLQ805
CAS No. :
578722-44-8
Molecular Formula :
C18H15FN4OS
Molecular Weight :
354.41

IUPAC Name:(E)-4-((3-allyl-2-hydroxybenzylidene)amino)-5-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-((3-Allyl-2-hydroxybenzylidene)amino)-3-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3-Allyl-2-hydroxybenzylidene)amino)-3-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione
IUPAC Name(E)-4-((3-allyl-2-hydroxybenzylidene)amino)-5-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD04029777
Molecular FormulaC18H15FN4OS
Molecular Weight354.41
SMILESS=C1NN=C(C2=CC=C(F)C=C2)N1/N=C/C3=CC=CC(CC=C)=C3O
InChI KeyHDFFVKRDGYAKET-RGVLZGJSSA-N
SynonymSALOR-INT L404500-1EA;2-ALLYL-6-(((3-(4-F-PH)-5-MERCAPTO-4H-1,2,4-TRIAZOL-4-YL)IMINO)METHYL)PHENOL;(E)-2-allyl-6-(((3-(4-fluorophenyl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)phenol;3H-1,2,4-Triazole-3-thione, 5-(4-fluorophenyl)-2,4-dihydro-4-[[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]amino]-
CAS No.578722-44-8

Synthetic Route by SureRoute

1. ACQSLQ805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVMYI832 route compound structure diagram
    ACVMYI83224019-66-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQSLQ805 route product structure diagram
    ACQSLQ805578722-44-8
Inquiry

2. ACQSLQ805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQSLQ805 route product structure diagram
    ACQSLQ805578722-44-8
Inquiry

Comments (0)